跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臨床基因體學暨蛋白質體學碩士學位學程
臺北醫學大學
藥學院
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(45)
專案
(85)
研究成果
(3223)
資料集
(156)
指紋
查看啟用 臨床基因體學暨蛋白質體學碩士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse
62%
Cohort Study
54%
Disease
51%
Colorectal Cancer
47%
Neoplasm
46%
Inflammation
42%
Chronic Kidney Failure
38%
IC50
33%
Lung Cancer
31%
Breast Cancer
25%
Cytotoxicity
24%
Reactive Oxygen Metabolite
24%
Biological Marker
24%
Injury
23%
Liver Cell Carcinoma
22%
Histone Deacetylase Inhibitor
22%
Anticarcinogen
22%
Chronic Obstructive Lung Disease
21%
Non Small Cell Lung Cancer
21%
Traumatic Brain Injury
19%
Epidermal Growth Factor Receptor
19%
Tumor Growth
19%
Diabetes Mellitus
18%
Pharmacokinetics
18%
Hemodialysis
18%
Antioxidant
17%
Brain Ischemia
17%
Histone Deacetylase
17%
Tumor Necrosis Factor
17%
Colon Cancer
17%
Tubulin
16%
Cardiovascular Disease
16%
Alzheimer's Disease
15%
Macrogol
15%
Phosphotransferase
14%
High Performance Liquid Chromatography
14%
Histone Deacetylase 6
14%
Adverse Event
14%
Chemotherapy
14%
Cancer Growth
14%
Western Blot
14%
Mouse Model
14%
Prevalence
14%
Prostate Cancer
14%
Caspase 3
13%
Combination Therapy
13%
Non Insulin Dependent Diabetes Mellitus
13%
Protein P53
13%
Drug Delivery System
12%
Micelle
12%
Cytokine
12%
Asthma
12%
Parkinson's Disease
12%
Polycyclic Aromatic Hydrocarbon
12%
Cell Viability
12%
Nanoparticle
12%
Sleep Disordered Breathing
12%
Doxorubicin
12%
Lung Adenocarcinoma
12%
Lipopolysaccharide
11%
Randomized Controlled Trial
11%
Interleukin 6
11%
Cisplatin
11%
Hydroxamic Acid
11%
Antitumor Activity
10%
Placebo
10%
Ethanol
10%
Nephrotoxicity
10%
Long Term Exposure
10%
Pancreas Cancer
10%
End Stage Renal Disease
10%
Infection
10%
Carcinogenesis
10%
Receptor
10%
Hyperlipidemia
10%
Well Water
10%
Nuclear Factor
10%
Bioavailability
10%
Metastasis
9%
Antiproliferative Activity
9%
Cigarette Smoking
9%
Calcium Ion
9%
Clinical Trial
9%
Survival Rate
9%
Symptom
9%
Case-Control Study
9%
Mitogen Activated Protein Kinase
9%
Vasculotropin
9%
Transitional Cell Carcinoma
9%
Drug Release
8%
Small Interfering RNA
8%
Tablet
8%
Chitosan
8%
Gelatinase B
8%
Anti-Inflammatory Drug
8%
Bladder Cancer
8%
Wound Healing
8%
Neuroprotective Agent
8%
Nitric Oxide
8%
Medicine and Dentistry
Cohort Analysis
42%
Apoplexy
39%
Chronic Kidney Disease
32%
Malignant Neoplasm
30%
In Vitro
28%
Cancer Cell
27%
Programmed Cell Death
24%
Disease
23%
Colorectal Cancer
22%
Neoplasm
21%
Hazard Ratio
21%
Odds Ratio
19%
Biological Marker
18%
Meta-Analysis
18%
Breast Cancer
17%
Lung Cancer
17%
Diabetes
17%
Injury
16%
Metastatic Carcinoma
16%
Traumatic Brain Injury
15%
Chronic Obstructive Pulmonary Disease
15%
Brain Ischemia
15%
Systematic Review
14%
Signal Transduction
13%
Retrospective Cohort Study
12%
Cell Proliferation
12%
Randomized Controlled Trial
12%
Alzheimer's Disease
12%
Particular Matter 2.5
11%
Maturity Onset Diabetes of the Young
10%
Hemodialysis
10%
End Stage Renal Disease
10%
Autophagy
10%
Proportional Hazards Model
10%
Diabetes Mellitus
10%
Rectum Cancer
9%
Cancer Growth
9%
Gene Expression
9%
Drug Therapy
9%
Hepatocellular Carcinoma
9%
Tumor Progression
9%
Cytotoxicity
8%
Atmospheric Aerosol
8%
Cancer Therapy
8%
Cardiovascular Disease
8%
Cell Migration
8%
Parkinson's Disease
8%
Obstructive Sleep Apnea
8%
Isotopes of Calcium
8%
Prevalence
8%
Acute Kidney Injury
8%
Symptom
8%
Urinary System
8%
Oxidative Stress
8%
Logistic Regression Analysis
7%
Upregulation
7%
Health Care Cost
7%
COVID-19
7%
Colon Cancer
7%
Medicine
7%
Adverse Event
7%
Histone Deacetylase
7%
Epidermal Growth Factor Receptor
7%
Non Small Cell Lung Cancer
7%
4 Iodo 2,5 Dimethoxyamphetamine
7%
Kidney Function
7%
Survival Rate
6%
Ischemic Heart Disease
6%
Infection
6%
Cardiovascular System
6%
Activating Transcription Factor 3
6%
Reactive Oxygen Species
6%
Xenograft
6%
Case-Control Study
6%
Endothelial Cell
6%
Calcium Ion
6%
Angiogenesis
5%
Carcinogenesis
5%
Extracellular Matrix
5%
Epithelial Cell
5%
Histone Deacetylase Inhibitor
5%
Elderly Patient
5%
microRNA
5%
Cell Death
5%
Nephropathy
5%
Coronary Artery
5%
Supplementation
5%
Influenza Vaccination
5%
Kawasaki Disease
5%
Transitional Cell Carcinoma
5%
Combination Therapy
5%
Protein P53
5%
IC50
5%
Computer Assisted Tomography
5%
Antioxidant
5%
Endothelial Progenitor Cell
5%
Vascular Smooth Muscle Cell
5%
Intensive Care Unit
5%
Surgery
5%
Blood Pressure
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
71%
Mouse
27%
Cohort Study
24%
Signal Transduction
22%
Gene Expression
19%
Single-Nucleotide Polymorphism
19%
Cell Migration
19%
Colon
17%
Cell Proliferation
16%
Messenger RNA
15%
Anticancer
15%
Genotyping
15%
Autophagy
14%
Proteomics
14%
Promoter Region
13%
Upregulation
13%
Epidermal Growth Factor Receptor
13%
Tumor Progression
13%
Cell Death
13%
MicroRNA
13%
Carcinogenesis
12%
Genetics
12%
Protein Expression
12%
Hemodialysis
12%
Cell Growth
11%
Glucose-Regulated Protein
11%
Genetic Divergence
11%
Allele
10%
Genome-Wide Association Study
10%
Eicosanoid Receptor
10%
down Regulation
10%
Phosphotransferase
10%
Kinase
10%
Methylation
10%
Histone Deacetylase
9%
Mesenchymal-Epithelial Transition
9%
P53
9%
Oxidative Stress
9%
IC50
8%
Western Blot
8%
Alternative Splicing
8%
Thrombomodulin
8%
Macrophage
8%
Enzyme
8%
Angiogenesis
8%
Homeostasis
8%
Catenin
7%
Cytotoxicity
7%
Survival Rate
7%
Cell Cycle
7%
Genetic Polymorphism
7%
Heat Shock Protein
7%
Transcription
7%
Overall Survival
7%
Isoform
7%
Protein Motif
6%
RNA Recognition Motif
6%
Fibroblast
6%
Tau
6%
Mitochondrion
6%
Prevalence
6%
Interleukin 8
6%
Adipocyte
6%
Lipid
6%
Case-Control Study
6%
Hypoxia Inducible Factor 1
6%
Drug Resistance
6%
Metabolic Pathway
5%
Kidney Function
5%
Blood Level
5%
Protein Kinases
5%
Caspase 3
5%
Caspase
5%
Transcription Factors
5%
Small Interfering RNA
5%
Skeletal Muscle
5%
Glycosylation
5%
DNA Repair
5%
Low-Density Lipoprotein
5%
Cyclooxygenase
5%
Particulate Matter
5%
K-Complex
5%
Antineoplastic Activity
5%
Synapsin I
5%
Wild Type
5%
Tubulin
5%
Normal Human
5%
Tumor Necrosis Factor
5%
Doxorubicin
5%
Cell Viability
5%
Heme Oxygenase
5%
Stem Cell
5%
Gene Polymorphism
5%